Oasmia Pharmaceutical receives market approval for its Anti-Cancer Drug Doxophos® in Russia - Nasdaq

Oasmia Pharmaceutical receives market approval for its Anti-Cancer Drug Doxophos® in Russia Nasdaq ... Ewing's sarcoma, soft tissue sarcoma, neuroblastoma, rhabdomyosarcoma, Wilms' tumor, breast carcinoma, endometrial cancer, ovarian carcinoma, germ cell tumors, prostatic carcinoma, lung cancer, gastric carcinoma, head and neck cancer and thyroid ... and more »

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2hFZQA0
via IFTTT